Make scientific figures in minutes

Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software

search icon

Try a synonym, or sign up to request an icon from the app.

Microglia (ameboid)

Microglia (ameboid) - Editable icon of A blob-shaped ameboid microglia cell.
[{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b3a0/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b3a0/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39f/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39f/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39e/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39e/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39d/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39d/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39c/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39c/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39b/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39b/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b39a/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b39a/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b399/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b399/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b398/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b398/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b397/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b397/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b396/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b396/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b395/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b395/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b394/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b394/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b393/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b393/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b392/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b392/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b391/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b391/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b390/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b390/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38f/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38f/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38e/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38e/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38d/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38d/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38c/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38c/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38b/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38b/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b38a/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b38a/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b389/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b389/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b388/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b388/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b387/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b387/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b386/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b386/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b385/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b385/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b384/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b384/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b383/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b383/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b382/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b382/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b381/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b381/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b380/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b380/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37f/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37f/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37e/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37e/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37d/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37d/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37c/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37c/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37b/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37b/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b37a/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b37a/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b379/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b379/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b378/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b378/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b377/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b377/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b376/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b376/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b375/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b375/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b374/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b374/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b373/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b373/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b372/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b372/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b371/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b371/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b370/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b370/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b36f/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b36f/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b36e/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b36e/60e36c289b713c0026b26201.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6165f050750572002977b36d/60e36c289b713c0026b26201.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6165f050750572002977b36d/60e36c289b713c0026b26201.png"}]
Keywords
microglia,neuroglia,glial cell,neuron,macrophage,ameboid,amoeboid,branching,process,brain,spinal cord,active immune defense,immune defense,immune,central nervous system,cns,plastic,brain maintenance,scavenge,survey,potassium,brain function,neuroprotective,rewiring,white matter,fountains of microglia,corpus callosum,popular neuroscience icons,microglia
Image types

Microglia (ameboid) icon JPEG

Microglia (ameboid) icon PNG

Microglia (ameboid) icon SVG

Microglia (ameboid) icon GIF

Join 1,500,000 other scientists on BioRender

Sign up for your free account and start creating scientific figures faster today
SIGN UP FREE
Decorative Chat Icon

FAQ

What is BioRender?
BioRender is a web‑based software that helps you create scientific figures in minutes. Use this Microglia (ameboid) icon along with our library of more than 30,000 life science icons.
Can I use this icon in a BioRender figure or scientific illustration?
Yes, the Microglia (ameboid) is fully integrated into BioRender’s drag-and-drop platform. You can easily add it to any scientific figure, workflow, or poster, whether you’re building from scratch or starting with a BioRender template.
Is the Microglia (ameboid) icon customizable in BioRender?
Most icons in BioRender, including the Microglia (ameboid) icon, are customizable. You can adjust icon size, colors, and positioning, and add custom labels to tailor the design to your specific research context.
How are scientists using the Microglia (ameboid) icon in their work?
BioRender users often use the Microglia (ameboid) icon in posters, grant applications, educational materials, and graphical abstracts. It’s especially useful for projects involving Cell Types.
Can I export figures that include the Microglia (ameboid) icon for publication or presentations?
Yes, figures containing the Microglia (ameboid) icon can be exported in multiple formats, including PNG, JPG, PDF, and SVG. High-resolution and vector exports are available on paid plans, making them ideal for journals, slide decks, and print materials.
Is the Microglia (ameboid) icon used in BioRender templates or poster layouts?
Many BioRender templates include icons like the Microglia (ameboid) icon — especially those focused on Cell Types. You can search BioRender’s template library or add this icon manually to any canvas.

Looking for science content?

Browse 50K+ icons and templates that are peer-reviewed, easy to use, and free.

Find yours now